Proteomics Facility
- Research Resources
- Core Facilities and Services
- Proteomics Facility
Overview
The goal of the MD Anderson Proteomics Core Facility is to deliver high-quality, reproducible and actionable proteomics data that accelerates discoveries in cancer biology and supports translational and clinical research. Therefore, our expert team is equipped with state-of-the-art equipment for sample preparation and data-acquisition for comprehensive proteomics analysis.
We offer an end-to-end full-service approach, including project consultation, sample preparation, LC-MS/MS analysis and data interpretation support. Our portfolio includes global proteome profiling, post-translational modification analysis (e.g., phosphoproteomics) and advanced workflows such as immunopeptidomics, spatial and single-cell proteomics and integrated multi-omics strategies are currently under development.
Our team is dedicated to a highly collaborative approach and thus works closely with investigators to ensure robust experimental design and meaningful biological insights. Learn more about proteomics.
Getting Started
Please reach out to our team via proteomics@mdanderson.org to schedule an initial onboarding meeting. We will discuss your project, define your needs, and identify the best approach to achieve your research goals.
Impact
The team supports all levels of research with a strong focus on cancer from discovery to clinical applications. Our expertise in mass spectrometry and advanced workflows makes cutting-edge proteomics accessible and impactful for projects of all sizes. We help investigators generate high-quality data for mechanistic insights, biomarker discovery and precision medicine.
Acknowledgment
Please use the following text when acknowledging the core: "Data were generated in part through the use of the Proteomics Core at MD Anderson Cancer Center."
Contact
Director: Dominic Helm, Ph.D.
Scientific Director: Sara Zanivan, Ph.D.
Email: proteomics@mdanderson.org
Phone: 346-723-7627
Location: 2SCR3.3027
We are excited to be ramping up our efforts to bring the MD Anderson Proteomics Core Facility to full operational capacity.
While services are currently limited as we launch, we are committed to expanding rapidly and delivering cutting-edge proteomics solutions to support your research.